Literature DB >> 15943620

Indirect recognition of MHC class I allopeptides accelerates lung allograft rejection in miniature swine.

Tsuyoshi Shoji1, John C Wain, Stuart L Houser, Louis C Benjamin, Douglas R Johnston, Ruediger Hoerbelt, Rebecca S Hasse, Richard S Lee, Ashok Muniappan, Dax A Guenther, Marjory A Bravard, Levi G Ledgerwood, David H Sachs, Mohamed H Sayegh, Joren C Madsen, James S Allan.   

Abstract

The role of indirect allorecognition in graft rejection is examined in two experiments using a swine lung transplantation model. First, two swine received class I mismatched grafts without immunosuppression; another two recipients were treated postoperatively with cyclosporine (CsA). These swine exhibited acute and chronic rejection, respectively. All four recipients developed T-cell reactivity to donor-derived class I major histocompatibility complex (MHC) peptides. Second, six swine were immunized with synthetic donor-derived class I allopeptides prior to transplantation. Control groups consisted of nonimmunized recipients (n = 6) and recipients immunized with an irrelevant peptide (n = 3). These recipients all received a 12-day course of post-operative CsA. Swine immunized with allopeptides exhibited accelerated graft rejection, as compared to both control groups (p < 0.01 and p = 0.03, respectively). Within the experimental group, the dominant histologic finding was acute rejection (AR). Obliterative bronchiolitis (OB) was seen in the graft with the longest survival. Both control groups showed a lesser degree of AR, with four out of six nonimmunized swine ultimately developing OB. These studies suggest that indirect allorecognition is operative during lung allograft rejection, and that pre-transplant sensitization to donor-derived MHC allopeptides can accelerate graft rejection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943620     DOI: 10.1111/j.1600-6143.2005.00925.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  6 in total

1.  The role of indirect recognition of MHC class I and II allopeptides in a fully mismatched miniature swine model of lung transplantation.

Authors:  H Sahara; T Shoji; C Y Ng; M J Weiss; A Muniappan; D A Guenther; S L Houser; A C Pujara; J K Sayre; J C Wain; D H Sachs; J C Madsen; J S Allan
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

2.  Update on Chronic Lung Allograft Dysfunction.

Authors:  Jason M Gauthier; Ramsey R Hachem; Daniel Kreisel
Journal:  Curr Transplant Rep       Date:  2016-08-02

3.  Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants.

Authors:  Mikio Okazaki; Andrew E Gelman; Jeremy R Tietjens; Aida Ibricevic; Christopher G Kornfeld; Howard J Huang; Steven B Richardson; Jiaming Lai; Joel R Garbow; G Alexander Patterson; Alexander S Krupnick; Steven L Brody; Daniel Kreisel
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-23       Impact factor: 6.914

4.  Repetitive gastric aspiration leads to augmented indirect allorecognition after lung transplantation in miniature swine.

Authors:  Andrew J Meltzer; Matthew J Weiss; Gregory R Veillette; Hisashi Sahara; Choo Y Ng; Meghan E Cochrane; Stuart L Houser; David H Sachs; Bruce R Rosengard; Joren C Madsen; John C Wain; James S Allan
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

5.  Tolerogenicity of donor major histocompatibility complex-matched skin grafts in previously tolerant Massachusetts general hospital miniature swine.

Authors:  Joshua Weiner; Joseph Scalea; Yoshinori Ishikawa; Masayoshi Okumi; Adam Griesemer; Atsushi Hirakata; Justin Etter; Bradford Gillon; Shannon Moran; Akira Shimizu; Kazuhiko Yamada; David H Sachs
Journal:  Transplantation       Date:  2012-12-27       Impact factor: 4.939

Review 6.  Immunosuppression for lung transplantation.

Authors:  Choo Y Ng; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.